These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 29500585)

  • 1. Comparing the effects of oxazepam and diazepam in actual highway driving and neurocognitive test performance: a validation study.
    Jongen S; Vuurman EFPM; Ramaekers JG; Vermeeren A
    Psychopharmacology (Berl); 2018 Apr; 235(4):1283-1294. PubMed ID: 29500585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On-the-road driving performance the morning after bedtime use of suvorexant 15 and 30 mg in healthy elderly.
    Vermeeren A; Vets E; Vuurman EF; Van Oers AC; Jongen S; Laethem T; Heirman I; Bautmans A; Palcza J; Li X; Troyer MD; Wrishko R; McCrea J; Sun H
    Psychopharmacology (Berl); 2016 Sep; 233(18):3341-51. PubMed ID: 27424295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity and validity of psychometric tests for assessing driving impairment: effects of sleep deprivation.
    Jongen S; Perrier J; Vuurman EF; Ramaekers JG; Vermeeren A
    PLoS One; 2015; 10(2):e0117045. PubMed ID: 25668292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On-the-Road Driving Performance the Morning after Bedtime Use of Suvorexant 20 and 40 mg: A Study in Non-Elderly Healthy Volunteers.
    Vermeeren A; Sun H; Vuurman EF; Jongen S; Van Leeuwen CJ; Van Oers AC; Palcza J; Li X; Laethem T; Heirman I; Bautmans A; Troyer MD; Wrishko R; McCrea J
    Sleep; 2015 Nov; 38(11):1803-13. PubMed ID: 26039969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Residual effects of middle-of-the-night administration of zaleplon and zolpidem on driving ability, memory functions, and psychomotor performance.
    Verster JC; Volkerts ER; Schreuder AH; Eijken EJ; van Heuckelum JH; Veldhuijzen DS; Verbaten MN; Paty I; Darwish M; Danjou P; Patat A
    J Clin Psychopharmacol; 2002 Dec; 22(6):576-83. PubMed ID: 12454557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On-the-road driving performance the morning after bedtime administration of lemborexant in healthy adult and elderly volunteers.
    Vermeeren A; Jongen S; Murphy P; Moline M; Filippov G; Pinner K; Perdomo C; Landry I; Majid O; Van Oers ACM; Van Leeuwen CJ; Ramaekers JG; Vuurman EFPM
    Sleep; 2019 Apr; 42(4):. PubMed ID: 30597112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of intranasal esketamine (84 mg) and oral mirtazapine (30 mg) on on-road driving performance: a double-blind, placebo-controlled study.
    van de Loo AJAE; Bervoets AC; Mooren L; Bouwmeester NH; Garssen J; Zuiker R; van Amerongen G; van Gerven J; Singh J; der Ark PV; Fedgchin M; Morrison R; Wajs E; Verster JC
    Psychopharmacology (Berl); 2017 Nov; 234(21):3175-3183. PubMed ID: 28755104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next-day effects of ramelteon (8 mg), zopiclone (7.5 mg), and placebo on highway driving performance, memory functioning, psychomotor performance, and mood in healthy adult subjects.
    Mets MA; de Vries JM; de Senerpont Domis LM; Volkerts ER; Olivier B; Verster JC
    Sleep; 2011 Oct; 34(10):1327-34. PubMed ID: 21966064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highway driving performance and cognitive functioning the morning after bedtime and middle-of-the-night use of gaboxadol, zopiclone and zolpidem.
    Leufkens TR; Lund JS; Vermeeren A
    J Sleep Res; 2009 Dec; 18(4):387-96. PubMed ID: 19552733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of acute treatment with ramelteon, triazolam, and placebo on driving performance, cognitive function, and equilibrium function in healthy volunteers.
    Miyata A; Iwamoto K; Kawano N; Kohmura K; Yamamoto M; Aleksic B; Ebe K; Noda A; Noda Y; Iritani S; Ozaki N
    Psychopharmacology (Berl); 2015 Jun; 232(12):2127-37. PubMed ID: 25533998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A clinical trial on the acute effects of methadone and buprenorphine on actual driving and cognitive function of healthy volunteers.
    Strand MC; Vindenes V; Gjerde H; Mørland JG; Ramaekers JG
    Br J Clin Pharmacol; 2019 Feb; 85(2):442-453. PubMed ID: 30515857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of alprazolam on driving ability, memory functioning and psychomotor performance: a randomized, placebo-controlled study.
    Verster JC; Volkerts ER; Verbaten MN
    Neuropsychopharmacology; 2002 Aug; 27(2):260-9. PubMed ID: 12093599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Residual effects of esmirtazapine on actual driving performance: overall findings and an exploratory analysis into the role of CYP2D6 phenotype.
    Ramaekers JG; Conen S; de Kam PJ; Braat S; Peeters P; Theunissen EL; Ivgy-May N
    Psychopharmacology (Berl); 2011 May; 215(2):321-32. PubMed ID: 21246188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidepressants and driver impairment: empirical evidence from a standard on-the-road test.
    Ramaekers JG
    J Clin Psychiatry; 2003 Jan; 64(1):20-9. PubMed ID: 12590619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does a medicinal dose of kava impair driving? A randomized, placebo-controlled, double-blind study.
    Sarris J; Laporte E; Scholey A; King R; Pipingas A; Schweitzer I; Stough C
    Traffic Inj Prev; 2013; 14(1):13-7. PubMed ID: 23259514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Residual effects of low-dose sublingual zolpidem on highway driving performance the morning after middle-of-the-night use.
    Vermeeren A; Vuurman EF; Leufkens TR; Van Leeuwen CJ; Van Oers AC; Laska E; Rico S; Steinberg F; Roth T
    Sleep; 2014 Mar; 37(3):489-96. PubMed ID: 24587571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validating lane drifts as a predictive measure of drug or sleepiness induced driving impairment.
    Vinckenbosch FRJ; Vermeeren A; Verster JC; Ramaekers JG; Vuurman EF
    Psychopharmacology (Berl); 2020 Mar; 237(3):877-886. PubMed ID: 31897572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Driving performance and neurocognitive skills of long-term users of sedating antidepressants.
    van der Sluiszen NNJJM; Vermeeren A; van Dijken JH; J A E van de Loo A; Veldstra JL; de Waard D; C Verster J; A Brookhuis K; Ramaekers JG
    Hum Psychopharmacol; 2021 Jan; 36(1):1-12. PubMed ID: 33001492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MDMA and alcohol effects, combined and alone, on objective and subjective measures of actual driving performance and psychomotor function.
    Kuypers KP; Samyn N; Ramaekers JG
    Psychopharmacology (Berl); 2006 Sep; 187(4):467-75. PubMed ID: 16830130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A dose-ranging study of the effects of mequitazine on actual driving, memory and psychomotor performance as compared to dexchlorpheniramine, cetirizine and placebo.
    Theunissen EL; Vermeeren A; van Oers AC; van Maris I; Ramaekers JG
    Clin Exp Allergy; 2004 Feb; 34(2):250-8. PubMed ID: 14987305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.